Profile: EUSA Pharma is a pharmaceutical company. We focus on in-licensing, developing and marketing late-stage oncology, pain control & critical care products. Our Caphosol® is designed to moisten, lubricate and clean the oral cavity including THE mucosa of the mouth, tongue & oropharynx. It is used as an adjunct to standard oral care in the prevention and treatment of the mucositis that is caused by radiation or high dose OF chemotherapy. It is indicated for dryness of the mouth and oropharynx regardless of the cause, or whether the conditions are temporary or permanent. Our ProstaScint® is an imaging agent that helps to locate and identify previously diagnosed prostate cancer. It circulates through the body and attaches to prostate specific membrane antigen (PSMA) which is located on prostate cancer cells.

The company has revenues of USD 10-25 Million. NASDAQ:CYTO (SEC Filings)